Avinash D Khadela (Avinash Khadela)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 36

Top Topics

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Diffusion Weighted

Epidermal Growth Factor Receptor

Top Venues

Medical oncology (Northwood, London, England)

Journal of the Egyptian National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Publications

Avinash D Khadela, Kaivalya Megha, Vraj B Shah, Shruti Soni, Aayushi C Shah, Hetvi Mistry, Shelly Bhatt, Manthan Merja
Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers. Clinical Medicine Insights. Oncology 18 (2024)
Avinash D Khadela, Bhavarth Dave, Yatvi Premal, Nishi Patel, Devang Sadhwani
The Phenytoin Ataxia Enigma Unveiled ''A Case Report''. Journal of pharmacy practice (2024)
Prashantkumar Patel, Hemraj Singh Rajput, Khushboo Chavda, Smit Mistry, Sandesh Bhagat, Rajesh Hadia, Moinuddin Saiyed, Avinash D Khadela
Assessing the effectiveness of gabapentin in paclitaxel-induced arthralgia, myalgia, and neuropathic pain: An observational, cohort study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Avinash D Khadela, Kaivalya Megha, Vraj B Shah, Shruti Soni, Aayushi C Shah, Hetvi Mistry, Shelly Bhatt, Manthan Merja
Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers. Clinical Medicine Insights. Oncology 18 (2024)
Deval K Rana, Tithi S Shah, Mansi H Rohit, Nayankumar Harshadkumar Patel, Avinash D Khadela, Yaksh P Oza, Jignaben Krunal Padhiyar
Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial. Mycoses 67 (1) (2024)
Deval K Rana, Tithi S Shah, Mansi H Rohit, Nayankumar Harshadkumar Patel, Avinash D Khadela, Yaksh P Oza, Jignaben Krunal Padhiyar
Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial. Mycoses 67 (1) (2024)
Avinash D Khadela, Yesha Shah, Priya Mistry, Kunjan Bodiwala, Avinash Cb
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technology in cancer research & treatment 22 (2023)
Avinash D Khadela, Vivek P Chavda, Humzah Postwala, Ramya Ephraim, Vasso Apostolopoulos, Yesha Shah
Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer. Cancers 15 (2) (2023)
Avinash D Khadela, Yesha Shah, Priya Mistry, Kunjan Bodiwala, Avinash Cb
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technology in cancer research & treatment 22 (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Avinash D Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Avinash D Khadela, Vivek P Chavda, Humzah Postwala, Ramya Ephraim, Vasso Apostolopoulos, Yesha Shah
Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer. Cancers 15 (2) (2023)
Avinash D Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Avinash D Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Avinash D Khadela, Yesha Shah, Priya Mistry, Kunjan Bodiwala, Avinash Cb
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technology in cancer research & treatment 22 (2023)
Avinash D Khadela, Humzah Postwala, Deval Rana, Hetvi Dave, Ketan Ranch, Sai H S Boddu
A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer. Medical oncology (Northwood, London, England) 40 (5) (2023)
Vivek P Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K Singla, Avinash D Khadela, Lalitkumar K Vora, Vladimir N Uversky
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15 (4) (2023)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Avinash D Khadela, Yesha Shah, Priya Mistry, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Shruti Soni, Aayushi C Shah, Aanshi J Pandya, Kaivalya Megha, Nirjari Kothari, Avinash Cb
Unveiling the antibody-drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon. Medical oncology (Northwood, London, England) 40 (1) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Vivek P Chavda, Shailvi Soni, Lalitkumar K Vora, Shruti Soni, Avinash D Khadela, Jinal Ajabiya
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10 (12) (2022)
Avinash D Khadela, Yesha Shah, Priya Mistry, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Shruti Soni, Kaivalya Megha, Aayushi C Shah, Aanshi J Pandya, Nirjari Kothari, Ishika Shah, C B Avinash
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Vivek P Chavda, Shruti Soni, Kaivalya Megha, Aanshi J Pandya, Lalitkumar K Vora
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Avinash D Khadela, Shruti Soni, Kaivalya Megha, Aayushi C Shah, Aanshi J Pandya, Nirjari Kothari, Ishika Shah, C B Avinash
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Shruti Soni, Kaivalya Megha, Aayushi C Shah, Aanshi J Pandya, Nirjari Kothari, Ishika Shah, C B Avinash
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Yesha Shah, Priya Mistry, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Shruti Soni, Kaivalya Megha, Aayushi C Shah, Aanshi J Pandya, Nirjari Kothari, Ishika Shah, C B Avinash
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Vivek P Chavda, Shruti Soni, Kaivalya Megha, Aanshi J Pandya, Lalitkumar K Vora
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Avinash D Khadela, Shruti Soni, Kaivalya Megha, Aayushi C Shah, Aanshi J Pandya, Nirjari Kothari, Ishika Shah, C B Avinash
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical oncology (Northwood, London, England) 40 (1) (2022)
Avinash D Khadela, Vivek P Chavda, Shruti Soni, Kaivalya Megha, Aanshi J Pandya, Lalitkumar K Vora
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Avinash D Khadela, Bhavin Vyas, Vishal Bhikadiya, Prakshavi Naik
Impact of clinical pharmacist services on quality adjusted life years in head and neck cancer patients. International journal of clinical pharmacy 43 (5) (2021)
Avinash D Khadela, Vishal Bhikadiya, Bhavin Vyas
Impact of oncology pharmacist services on humanistic outcome in patients with breast cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)